1. Home
  2. MMA vs BNGO Comparison

MMA vs BNGO Comparison

Compare MMA & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alta Global Group Limited

MMA

Alta Global Group Limited

HOLD

Current Price

$0.42

Market Cap

13.9M

Sector

N/A

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.22

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMA
BNGO
Founded
2013
2003
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
12.5M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
MMA
BNGO
Price
$0.42
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
15.8M
148.2K
Earning Date
05-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.35
$1.00
52 Week High
$2.00
$4.10

Technical Indicators

Market Signals
Indicator
MMA
BNGO
Relative Strength Index (RSI) 44.05 51.37
Support Level $0.36 $1.14
Resistance Level $0.44 $1.35
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 12.63 38.46

Price Performance

Historical Comparison
MMA
BNGO

About MMA Alta Global Group Limited

MMA Inc develops technology solutions for the martial arts and combat sports sector. Its platform is designed to support gyms and related businesses by improving areas such as sales channels, customer onboarding, and member engagement. The platform also connects participants, gyms, and communities within the sector, enabling digital management and interaction.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: